ETHZilla Corporation (ATNFW) changes name from 180 Life Sciences and trades as ETHZ

Rhea-AI Filing Summary

ETHZilla Corporation, formerly known as 180 Life Sciences Corp., reported that it has changed its corporate name to ETHZilla Corporation, effective August 18, 2025. The company’s common stock now trades on The NASDAQ Stock Market LLC under the symbol ETHZ, and its warrants to purchase shares of common stock trade under the symbol ETHZW. The change is described in a press release furnished as an exhibit, which is not treated as filed for liability purposes under the securities laws.

false 0001690080 0001690080 2025-08-18 2025-08-18 0001690080 ATNF:CommonStockParValue0.0001PerShareMember 2025-08-18 2025-08-18 0001690080 ATNF:WarrantsToPurchaseSharesOfCommonStockMember 2025-08-18 2025-08-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 18, 2025

ETHZilla Corporation

(Exact Name of Registrant as Specified in Charter)

Delaware		001-38105		90-1890354
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2875 South Ocean Blvd, Suite 200 Palm Beach, FL		33480
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (650) 507-0669

180 Life Sciences Corp.

(Former name or former address, if changed since last report).

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ETHZ		The NASDAQ Stock Market LLC
Warrants to purchase shares of Common Stock		ETHZW		The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On August 18, 2025, ETHZilla Corporation (the “Company”) issued a press release announcing the Company’s name change from 180 Life Sciences Corp. to ETHZilla Corporation, effective August 18, 2025. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference.

The information in this Item 7.01 of this Current Report on Form 8-K, including the information contained in Exhibit 99.1 is being furnished to the U.S. Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release, dated August 18, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

1 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 18, 2025

	ETHZilla Corporation
	By:	/s/ Blair Jordan
		Name:	Blair Jordan
		Title:	Chief Executive Officer

2

FAQ

What did ETHZilla Corporation (ATNFW) disclose in this 8-K filing?

The company disclosed that it changed its name from 180 Life Sciences Corp. to ETHZilla Corporation, effective August 18, 2025, and furnished a related press release.

What is the new trading symbol for ETHZilla Corporation common stock?

The common stock of ETHZilla Corporation now trades on The NASDAQ Stock Market LLC under the symbol ETHZ.

How are the company’s warrants listed after the name change?

Warrants to purchase shares of ETHZilla Corporation common stock are listed on The NASDAQ Stock Market LLC under the symbol ETHZW.

Does the 8-K indicate when the name change became effective for ETHZilla Corporation?

Yes. The filing states that the name change from 180 Life Sciences Corp. to ETHZilla Corporation was effective on August 18, 2025.

Is the press release about ETHZilla Corporation’s name change considered filed with the SEC?

No. The press release attached as Exhibit 99.1 is furnished under Regulation FD and is expressly stated not to be deemed “filed” for purposes of Section 18 of the Exchange Act.

Who signed the 8-K on behalf of ETHZilla Corporation?

The report was signed on behalf of ETHZilla Corporation by Blair Jordan, the company’s Chief Executive Officer.